Company Monitoring Page for Roche

latest headlines for company on cafepharma

Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech
Fri, 04/12/13 - 01:56 pm
Tags:
biotech, M&A, Otsuka, Lundbeck, Gilead, Macrogenics, Roche, Chiasma, Edison Pharma, Dainippon, Moderna, AstraZeneca
Roche says no plans to change holding in Japan's Chugai
Reuters
Fri, 04/12/13 - 10:01 am
Tags:
Japan, Chugai, Roche
Roche First-Quarter Revenue Rises on U.S. Tamiflu Sales
Bloomberg
Thu, 04/11/13 - 11:37 am
Tags:
earnings, Roche
Isis: Big Pharma's Little Friend
Motley Fool
Tue, 04/9/13 - 09:47 am
Tags:
Isis Pharmaceuticals, Roche, Kynamro, Huntington's disease
Roche to use Isis's technology to develop brain disorder drug
Reuters
Mon, 04/8/13 - 12:54 pm
Tags:
Roche, Isis Pharmaceuticals, Huntington's disease, antisense
Yervoy-Zelboraf combo trial stopped on toxicity worries
Fierce Pharma
Thu, 04/4/13 - 02:05 pm
Tags:
Zelboraf, Yervoy, Bristol-Myers Squibb, melanoma, Roche
Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering
Seeking Alpha
Thu, 04/4/13 - 09:24 am
Tags:
Amgen, Amarantus BioSciences, Novartis, Gilead, biotech, Roche, Teva
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Thu, 04/4/13 - 09:13 am
Tags:
Celgene, Eli Lilly, Bristol-Myers Squibb, Roche, ONYX Pharmaceuticals, Pomalyst, Revlimid, Abraxane
Drugmakers to Benefit From Obama's Brain Initiative
Bloomberg
Wed, 04/3/13 - 08:45 am
Tags:
Obama, brain research, Pfizer, Roche, Eli Lilly
Dr. Reddy’s Announces the Launch of Zenatane™ (Isotretinoin Capsules USP)
Yahoo
Fri, 03/29/13 - 10:59 am
Tags:
Dr Reddy's, Zenatane, Accutane, generics, Roche
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/20/13 - 11:56 am
Tags:
lung cancer, Roche, Avastin, Tarceva, Astellas, Pfizer, Xalkori, Celgene, Abraxane, Gemzar, Alimta, Eli Lilly
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
Tags:
breast cancer, aromatase inhibitors, AstraZeneca, Novartis, Femara, Arimidex, SERMs, Nolvadex, Roche, Herceptin, GSK, Tykerb, Xeloda, Perjeta, Kadcyla, Immunogen, Lymphoseek, Navidea Biopharmaceuticals, Nexavar, ONYX Pharmaceuticals
New anti-inflammatory causes stir at ACC
Pharma Times, UK
Mon, 03/11/13 - 11:00 am
Tags:
anti-inflammatories, Genmab, Roche, inclacumab, angioplasty
This FDA Approval Is Actually a Big Deal
Motley Fool
Wed, 02/27/13 - 12:40 pm
Tags:
Kadcyla, Roche, Immunogen
Roche Peels Back The Curtain On Clinical Trial Data
Pharmalot
Wed, 02/27/13 - 12:16 pm
Tags:
Roche, clinical trials
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Tags:
Roche, Immunogen, Repros Therapeutics, Chelsea Therapeutics, Gilead Sciences, Vivus
FDA OKs Roche drug for late-stage metastatic breast cancer
Reuters
Fri, 02/22/13 - 11:01 am
Tags:
Roche, metastatic breast cancer, breast cancer, Kadcyla
Italian antitrust agency probes alleged Roche-Novartis cartel
Fierce Pharma
Wed, 02/20/13 - 12:12 pm
Tags:
Lucentis, Roche, Avastin, Italy, Novartis, antitrust
Roche Alzheimer’s Push May Gain From Obama Brain-Mapping Plan
Bloomberg
Tue, 02/19/13 - 09:39 am
Tags:
Roche, Alzheimer's disease, Eli Lilly, Brain Activity Map
ImmunoGen, Surprisingly Quiet Ahead Of FDA Decision
Seeking Alpha
Thu, 02/14/13 - 11:17 am
Tags:
Immunogen, FDA, trastuzumab, Roche

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.